Clinical trials
Phase 2 Lymphoma, T-Cell, Peripheral trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 1 |
| 2012 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Active, not recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The Lymphoma Academic Research Organisation | 2 |
| Acrotech Biopharma Inc. | 1 |
| Affimed GmbH | 1 |
| AstraZeneca | 1 |
| BeiGene | 1 |
| Celgene | 1 |
| Daiichi Sankyo | 1 |
| Kyowa Kirin Co., Ltd. | 1 |
| Lymphoma Study Association | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell, Peripheral | 13 |
| Lymphoma, T-Cell | 5 |
| Recurrence | 3 |
| Lymphoma | 2 |
| Lymphoma, T-Cell, Cutaneous | 2 |
| Hematologic Neoplasms | 1 |
| Immunoblastic Lymphadenopathy | 1 |
| Lymphoma, Extranodal NK-T-Cell | 1 |
| Lymphoma, Large-Cell, Anaplastic | 1 |
| Lymphoma, Non-Hodgkin | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.